Showing 1 - 10 of 30
This study shows that R&D cooperation can be used as an instrument to coordinate drug development portfolios among participating firms, which has crucial implications on the number of drugs offered on the market. Our study puts special attention to the fact that R&D cooperation, formed at...
Persistent link: https://www.econbiz.de/10010862368
In this paper, we specify a theoretical dynamic oligopoly model with regard to asymmetric firms. We then estimate a structural dynamic model of demand and pricing relations for the semiconductor industry. Using quarterly firm-level output and cost data as well as industry prices from 1974 to...
Persistent link: https://www.econbiz.de/10005345557
Persistent link: https://www.econbiz.de/10004317392
Persistent link: https://www.econbiz.de/10004338145
Theoretical models of information asymmetry have identified a trade-off between the desire to learn and the desire to prevent an opponent from learning private information. This paper reports a laboratory experiment that investigates if actual bidders account for this trade-off, using a...
Persistent link: https://www.econbiz.de/10009208960
In the last decades, technologies became more complex which increased the degree of uncertainty in R&D. To overcome the uncertainty, firms frequently engage in R&D collaborations, e.g., Research Joint Ventures (RJVs), and licensing agreements. While RJVs are well explored in the literature, very...
Persistent link: https://www.econbiz.de/10010723531
This paper evaluates how different lengths of entry regulation impact market structure and market performance using a dynamic structural model. We formulate an oligopoly model in the tradition of Ericson and Pakes (1995) and allow entry costs to vary over time. Firms have the opportunity to...
Persistent link: https://www.econbiz.de/10010670793
Persistent link: https://www.econbiz.de/10008375563
Persistent link: https://www.econbiz.de/10007748551
Persistent link: https://www.econbiz.de/10007861558